• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Cerezyme 400
    / Sanofi


    Active Ingredient
    Imiglucerase 400 U/Vial

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    400 IU

    partial basket chart 75687 9524

    Dosage

    Cerezyme® (imiglucerase) powder for solution for infusion is administered by intravenous infusion over 1-2 hours. Dosage should be individualized to each patient. Initial dosages range from 2.5 U/kg of body weight 3 times a week to 60 U/kg once every 2 weeks. 60 U/kg every 2 weeks is the dosage for which the most data are available. Disease severity may dictate that treatment be initiated at a relatively high dose or relatively frequent administration. Dosage adjustments should be made on an individual basis, and may increase or decrease, based on achievement of therapeutic goals as assessed by routine comprehensive evaluations of the patient’s clinical manifestations.
    See prescribing information for full details.


    Indications

    Long term enzyme replacement therapy in confirmed diagnosis of type 1 Gaucher disease.


    Contra-Indications

    See prescribing information for full details.


    Special Precautions

    See prescribing information for full details.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Manufacturer
    Genzyme Corporation
    CLOSE